Bristol-Myers Squibb (BMY) reported Q1 non-GAAP earnings Thursday of $1.80 per diluted share, compared with a loss of $4.40 a year earlier.

Analysts polled by FactSet expected $1.49.

Revenue for the quarter ended March 31 was $11.2 billion, down from $11.87 billion a year earlier.

Analysts surveyed by FactSet expected $10.7 billion.

The company said it increased its full-year 2025 non-GAAP earnings guidance to $6.70-$7.00 per share from $6.55-$6.85. Analysts surveyed by FactSet expect $6.74.

The company increased it full-year 2025 revenue guidance to about $45.8 billion-$46.8 billion from $45.5 billion. Analysts polled by FactSet expect $45.7 billion.

Bristol-Myers shares were 1.4% higher in premarket trading.